The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2008- 2011
PUBLICATIONS DURING THE PHD PROGRAM
- Imatinib treatment inhibits IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients.
Ciarcia R, Vitiello MT, Galdiero M, Pacilio C, Iovane V, d'Angelo D, Pagnini D, Caparrotti G, Conti D, Tomei V, Florio S, Giordano A.
J Cell Physiol. 2011 Sep 21 - New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
Indovina P, Giorgi F, Rizzo V, Khadang B, Schenone S, Di Marzo D, Forte IM, Tomei V, Mattioli E, D'Urso V, Grilli B, Botta M, Giordano A, Pentimalli F.
Oncogene. 2011 Jul 25 - Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats.
Aloisi AM, Ceccarelli I, Fiorenzani P, Maddalena M, Rossi A, Tomei V, Sorda G, Danielli B, Rovini M, Cappelli A, Anzini M, Giordano A.
Mol Pain. 2010 Oct 26;6:69. - Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, Luzzi A, Giorgi F, Hadjistilianou T, Toti P, Tomei V, Pentimalli F, Carugi A, Giordano A.
J Cell Physiol. 2010 Apr;223(1):143-50.
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
- Conference abstract title
Conference title, Date
Location
ACTIVITY DURING THE PHD PROGRAM
- 1st YEAR (a.a. 2008-09)
- 2nd YEAR (a.a. 2009-10)
- 3rd YEAR (a.a. 2010-11)
TRAINING PERIOD ABROAD
-
Hosting Institution Name
Location
Period dates
-
Hosting Institution Name
Location
Period dates